Immunome, Inc.
← Back to IMNM Overview

Immunome, Inc. (IMNM)

Profitability & Net Margin History

Current Net Margin

Immunome, Inc. currently has a net profit margin of .

Financial Fundamentals

IMNMQuarterly Data • 5Y View

Historical Margin Data

DateRev ($B)NI ($B)Net MarginChange (bps)
2025-12-310.00-0.07
2025-09-300.00-0.06
2025-06-300.00-0.04-1080.87%34223
2025-03-310.00-0.04-1423.10%150783
2024-12-310.00-0.08-2930.93%131238
2024-09-300.00-0.05-1618.56%9055
2024-06-300.00-0.04-1528.00%1105625
2024-03-310.00-0.13-12584.26%1016309
2023-12-310.00-0.09-2421.17%229929
2023-09-300.00-0.00-121.88%847
2023-06-300.00-0.01-130.35%5027
2023-03-310.00-0.00-180.63%
2022-12-310.00-0.01
2022-09-300.00-0.01
2022-06-300.00-0.01
2022-03-310.00-0.01
2021-12-310.00-0.01
2021-09-300.00-0.01
2021-06-300.00-0.01
2021-03-310.00-0.00
2020-12-310.00-0.00
2020-09-300.00-0.01
2020-06-300.00-0.00
2020-03-310.00-0.00
2019-12-310.00-0.00
2019-09-300.00-0.00
2019-06-300.00-0.00
2019-03-310.00-0.00

* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.